Moscow, June 23, 2015 - Public Joint Stock Company "Pharmstandard" (LSE: PHST, RTS: PHST RU) (the "Company") announces that it has been informed by Augment Investments Limited ("Augment"), a controlling shareholder of the Company, that in the frameworks of the Tender Offer Augment is obliged to purchase 17,461,550 GDRs, which in the aggregate constitutes 11.55% of the share capital of the Company.